Impact of Handover of Anesthesia Care on Adverse Postoperative Outcomes
NCT ID: NCT04016454
Last Updated: 2022-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1817 participants
INTERVENTIONAL
2019-06-21
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Information Transfer During Postoperative Handovers in the Post-anaesthesia Care Unit
NCT01973959
Impact of an Anesthesia Care Handover-Checklist on Adverse Perioperative Outcome
NCT04582513
Quality of Handover to a Post Anaesthesia Care Unit in a Children's Hospital
NCT02114866
Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery
NCT04013061
Interruptions, Teamwork, Stress and Patient Outcomes in the Operating Room
NCT04226391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal is to conduct a prospective, national, randomized-controlled, multicenter trial to investigate the effect of handover of anesthesia care on the occurrence of adverse outcomes in the perioperative period. The investigators hypothesizes that handover of anesthesia care does increase the risk for adverse outcomes. The primary outcome parameter is a combined endpoint consisting of all-cause mortality, readmission to any hospital, or major postoperative complications (including prolonged postoperative ventilation ≥ 48 h, major disruption of surgical wound, bleeding, pneumonia, atrial fibrillation, moderate or severe acute kidney injury, new onset of hemodialysis, cardiac arrest, myocardial infarction, sepsis, stroke, pulmonary embolism, deep venous thrombosis, shock, unplanned return to operating room) within 30 days of index surgery. Secondary endpoints are the individual criteria of the primary endpoint, hospital length of stay, ICU admission, and ICU length of stay. As the currently available data on handover of anesthesia care have not been obtained from prospective, randomized controlled trials, the results of the Handicap trial will bring new insights to anesthesia care to improve patients' outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Intervention group: handover of anesthesia
2. Control group: no handover of anesthesia
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
No handover of anesthesia care
Intervention
There will be one complete handover
Control group
Complete handover of anesthesia care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
There will be one complete handover
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Major surgeries with a duration of at least 2 h (requirement of postoperative admission to hospital for at least 1 night)
* ASA 3-4
* Informed consent
Exclusion Criteria
* Pregnancy, breastfeeding
* Patients participating in another interventional trial within the last 3 months
* Persons with any kind of dependency on the investigator or employed by the investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Else Kröner Fresenius Foundation
OTHER
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melanie Meersch, MD, PHD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Muenster, Dept. of Anesthesiology, Intensive Care and Pain Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Aachen
Aachen, , Germany
University Hospital Bochum
Bochum, , Germany
Kliniken der Stadt Köln gGmbH, Klinik für Anästhesiologie und operative Intensivmedizin
Cologne, , Germany
Klinikum Dortmund
Dortmund, , Germany
St. Josefs-Hospital Dortmund-Hörde
Dortmund, , Germany
Florence-Nightingale-Krankenhaus
Düsseldorf, , Germany
Universitätsmedizin Göttingen, Klinik für Anästhesiologie
Göttingen, , Germany
University Hospital Heidelberg
Heidelberg, , Germany
Kliniken Maria Hilf
Mönchengladbach, , Germany
University Hospital Muenster
Münster, , Germany
St. Franziskus Hospital
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Meersch M, Weiss R, Kullmar M, Bergmann L, Thompson A, Griep L, Kusmierz D, Buchholz A, Wolf A, Nowak H, Rahmel T, Adamzik M, Haaker JG, Goettker C, Gruendel M, Hemping-Bovenkerk A, Goebel U, Braumann J, Wisudanto I, Wenk M, Flores-Bergmann D, Bohmer A, Cleophas S, Hohn A, Houben A, Ellerkmann RK, Larmann J, Sander J, Weigand MA, Eick N, Ziemann S, Bormann E, Gerss J, Sessler DI, Wempe C, Massoth C, Zarbock A. Effect of Intraoperative Handovers of Anesthesia Care on Mortality, Readmission, or Postoperative Complications Among Adults: The HandiCAP Randomized Clinical Trial. JAMA. 2022 Jun 28;327(24):2403-2412. doi: 10.1001/jama.2022.9451.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-AnIt-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.